Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Introduction 5 Global Markets Direct Report Coverage 5 Genital Herpes - Overview 6 Genital Herpes - Therapeutics Development 7 Pipeline Overview 7 Pipeline by Companies 8 Pipeline by Universities/Institutes 11 Products under Development by Companies 12 Products under Development by Universities/Institutes 14 Genital Herpes - Therapeutics Assessment 15 Assessment by Target 15 Assessment by Mechanism of Action 17 Assessment by Route of Administration 19 Assessment by Molecule Type 21 Genital Herpes - Companies Involved in Therapeutics Development 23 Abivax SA 23 Admedus Ltd 23 AiCuris GmbH & Co KG 24 Biomere LLC 24 Foamix Pharmaceuticals Ltd 25 Genocea Biosciences Inc 25 GenVec Inc 26 Immune Design Corp 26 JN-International Medical Corp 27 NanoBio Corp 27 NanoViricides Inc 28 Profectus BioSciences Inc 28 Redbiotec AG 29 Sanofi Pasteur SA 29 Starpharma Holdings Ltd 30 Vaccibody AS 30 Vical Inc 31 Genital Herpes - Drug Profiles 32 ABX-196 - Drug Profile 32 acyclovir - Drug Profile 33 Aspidasept - Drug Profile 34 astodrimer - Drug Profile 35 G-103 - Drug Profile 40 GEN-003 - Drug Profile 41 genital herpes (virus like particle) vaccine - Drug Profile 47 genital herpes vaccine - Drug Profile 48 genital herpes vaccine - Drug Profile 51 genital herpes vaccine - Drug Profile 52 genital herpes vaccine - Drug Profile 53 genital herpes vaccine - Drug Profile 54 GV-2207 - Drug Profile 55 herpes simplex virus [type 1, 2] vaccine - Drug Profile 56 herpes simplex virus 2 vaccine - Drug Profile 57 herpes simplex virus 2 vaccine - Drug Profile 58 herpes simplex virus 2 vaccine - Drug Profile 59 herpes simplex virus 2 vaccine - Drug Profile 61 herpes simplex virus 2 vaccine - Drug Profile 62 HSV-529 - Drug Profile 63 NN-001 - Drug Profile 65 pritelivir - Drug Profile 66 Profavax HSV-1 - Drug Profile 69 Profavax HSV-2 - Drug Profile 70 Small Molecule for Genital Herpes - Drug Profile 71 Theravax HSV-1 - Drug Profile 72 Theravax HSV-2 - Drug Profile 73 VCLHB-01 - Drug Profile 74 VCLHM-01 - Drug Profile 76 VMTX-004 - Drug Profile 78 Genital Herpes - Dormant Projects 79 Genital Herpes - Discontinued Products 81 Genital Herpes - Product Development Milestones 82 Featured News & Press Releases 82 Appendix 94 Methodology 94 Coverage 94 Secondary Research 94 Primary Research 94 Expert Panel Validation 94 Contact Us 94 Disclaimer 95

List of Tables Number of Products under Development for Genital Herpes, H2 2017 Number of Products under Development by Companies, H2 2017 Number of Products under Development by Companies, H2 2017 (Contd..1), H2 2017 Number of Products under Development by Universities/Institutes, H2 2017 Products under Development by Companies, H2 2017 Products under Development by Companies, H2 2017 (Contd..1), H2 2017 Products under Development by Universities/Institutes, H2 2017 Number of Products by Stage and Target, H2 2017 Number of Products by Stage and Mechanism of Action, H2 2017 Number of Products by Stage and Route of Administration, H2 2017 Number of Products by Stage and Molecule Type, H2 2017 Genital Herpes - Pipeline by Abivax SA, H2 2017 Genital Herpes - Pipeline by Admedus Ltd, H2 2017 Genital Herpes - Pipeline by AiCuris GmbH & Co KG, H2 2017 Genital Herpes - Pipeline by Biomere LLC, H2 2017 Genital Herpes - Pipeline by Foamix Pharmaceuticals Ltd, H2 2017 Genital Herpes - Pipeline by Genocea Biosciences Inc, H2 2017 Genital Herpes - Pipeline by GenVec Inc, H2 2017 Genital Herpes - Pipeline by Immune Design Corp, H2 2017 Genital Herpes - Pipeline by JN-International Medical Corp, H2 2017 Genital Herpes - Pipeline by NanoBio Corp, H2 2017 Genital Herpes - Pipeline by NanoViricides Inc, H2 2017 Genital Herpes - Pipeline by Profectus BioSciences Inc, H2 2017 Genital Herpes - Pipeline by Redbiotec AG, H2 2017 Genital Herpes - Pipeline by Sanofi Pasteur SA, H2 2017 Genital Herpes - Pipeline by Starpharma Holdings Ltd, H2 2017 Genital Herpes - Pipeline by Vaccibody AS, H2 2017 Genital Herpes - Pipeline by Vical Inc, H2 2017 Genital Herpes - Dormant Projects, H2 2017 Genital Herpes - Dormant Projects, H2 2017 (Contd..1), H2 2017 Genital Herpes - Discontinued Products, H2 2017

Abivax SA Admedus Ltd AiCuris GmbH & Co KG Biomere LLC Foamix Pharmaceuticals Ltd Genocea Biosciences Inc GenVec Inc Immune Design Corp JN-International Medical Corp NanoBio Corp NanoViricides Inc Profectus BioSciences Inc Redbiotec AG Sanofi Pasteur SA Starpharma Holdings Ltd Vaccibody AS Vical Inc